Article Text
Abstract
Background Manitoba-oculo-tricho-anal (MOTA) syndrome is a rare condition defined by eyelid colobomas, cryptophthalmos and anophthalmia/microphthalmia, an aberrant hairline, a bifid or broad nasal tip, and gastrointestinal anomalies such as omphalocele and anal stenosis. Autosomal recessive inheritance had been assumed because of consanguinity in the Oji-Cre population of Manitoba and reports of affected siblings, but no locus or cytogenetic aberration had previously been described.
Methods and results This study shows that MOTA syndrome is caused by mutations in FREM1, a gene previously mutated in bifid nose, renal agenesis, and anorectal malformations (BNAR) syndrome. MOTA syndrome and BNAR syndrome can therefore be considered as part of a phenotypic spectrum that is similar to, but distinct from and less severe than, Fraser syndrome. Re-examination of Frem1bat/bat mutant mice found new evidence that Frem1 is involved in anal and craniofacial development, with anal prolapse, eyelid colobomas, telecanthus, a shortened snout and reduced philtral height present in the mutant mice, similar to the human phenotype in MOTA syndrome.
Conclusions The milder phenotypes associated with FREM1 deficiency in humans (MOTA syndrome and BNAR syndrome) compared to that resulting from FRAS1 and FREM2 loss of function (Fraser syndrome) are also consistent with the less severe phenotypes resulting from Frem1 loss of function in mice. Together, Fraser, BNAR and MOTA syndromes constitute a clinically overlapping group of FRAS–FREM complex diseases.
- MOTA syndrome
- BNAR syndrome
- Fraser syndrome
- FREM1
- FRAS1
- clinical genetics
- molecular genetics
- ophthalmology
Statistics from Altmetric.com
Footnotes
Funding This work was supported by The Eunice Kennedy Shriver National Institute of Child Health, National Institutes of Health (grant K08HD053476-01A1 to AS), the National Eye Institute, National Institutes of Health (grant R21EY019999-01 to AS), and the National Health and Medical Research Council and Monash University (Project Grant and Fellowship funding to IS). SEB is a Harry Weaver Neuroscience Scholar from the National Multiple Sclerosis Society.
Competing interests None.
Patient consent Obtained.
Ethics approval This study was conducted with the approval of the Committee for Human Research, UCSF.
Provenance and peer review Not commissioned; externally peer reviewed.